[Oncologic aspects of estrogen-replacement therapy].
The following problems are discussed in this short review: (1) General issues (drugs, dosage, indications); (2) Risk of cancer development in women receiving estrogen-replacement therapy (ERT); (3) Attempts to extend ERT to breast and endometrial carcinoma patients; (4) Difficulties involved, doubts and perspectives.